IS-06 - Challenging Cases - Neuromodulation

Friday, November 14, 2025

10:30 AM - 12:15 PM CT

Location: Lone Star Salon C

CE: 1.75

Moderator(s)

Vinita Singh, MD (she/her/hers)

Division Chief, Emory Pain Division,
Emory University School of Medicine, Georgia, United States

Nicholas Bremer, MD (he/him/his)

Medical Director Amelia Island
Jax Spine and Pain
Jacksonville Beach, Florida, United States

Shane Brogan, MB BCh (he/him/his)

Director of Pain Medicine
Huntsman Cancer Institute, University of Utah

Disclosure(s):

Vinita Singh, MD, MSCR: No financial relationships to disclose

Analyze patient presentations to determine possibility etiologies for loss of neurostimulation effectiveness.
Examine controversies in intrathecal analgesia, including medication combinations and systemic opioid weaning.
Apply troubleshooting techniques for suboptimal outcomes or complications related to neurostimulation therapy.
Address appropriate indications but challenging comorbidities—such as mental health conditions and high opioid use—when considering spinal cord stimulation.
Collaborate with peers and faculty for high-risk or atypical cases to create practical solutions you can use on Monday morning.

10:30 AM - 10:55 AM CT

Why Can There Be a Decreasing Analgesic Benefit From Spinal Cord Stimulation and What to Do About It?
Associate Faculty: Nicholas Bremer, MD (he/him/his) – Jax Spine and Pain
10:55 AM - 11:20 AM CT

Dealing with Appropriate Indications but Inappropriate Comorbidities (Mental Helath Issues, High Opioid Use, Others) in Patients for SCS
Speaker: Vinita Singh, MD (she/her/hers) – Emory University School of Medicine
11:20 AM - 11:50 AM CT

Controversies Around Intrathecal Analgesia - Combining Medications, Weaning Systemic Opioids
Speaker: Shane Brogan, MB BCh (he/him/his) – Huntsman Cancer Institute, University of Utah